Adalat Oros differs from general products in pharmacokinetic profiles, BayerSchering HealthCare says

Published: 2008-03-06 07:00:00
Updated: 2008-03-06 07:00:00
All once-daily nifedipine formulations are not pharmacokinetically the same, according to clinical data released by BayerSchering HealthCare on March 3.

Citing the theses published by British Journal of Clinical Pharmacology and Clinical Therapeutics, the company claims that when substituting ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.